Browsing Tag
Inc.
380 posts
Can balance-sheet cleanup unlock strategic optionality for NUBURU, Inc. in defense and security markets?
Find out how NUBURU, Inc.’s $8.4 million preferred equity restructuring could reshape its balance sheet and defense strategy momentum.
How Uber Technologies, Inc.’s Getir deal could reshape competition in Türkiye’s food and grocery delivery sector
Find out how Uber Technologies, Inc.’s agreement to acquire Getir’s Türkiye delivery business could reshape competition, margins, and platform strategy.
Axcelis Technologies, Veeco Instruments move closer to $4.4bn semiconductor equipment combination
Axcelis Technologies shareholders approve the Veeco Instruments merger. Find out what changes now, what risks remain, and what it means for investors.
PayPal resets leadership and doubles down on agentic commerce as board signals urgency on execution
PayPal Holdings, Inc. appoints Enrique Lores as CEO and acquires Cymbio. Find out how leadership change and agentic commerce shape its next phase.
How P10, Inc.’s acquisition of Stellus Capital Management reshapes scale economics in U.S. lower-middle market credit (NYSE: PX)
Discover how P10, Inc.’s $250M Stellus Capital acquisition reshapes its private credit strategy and what it means for investors and markets. Read more.
Frontage Laboratories adds oncology and radiolabeled capacity to Secaucus Phase I unit for integrated CRDMO execution
Frontage Laboratories expands early-phase clinical research in U.S. and China. Find out how its oncology and AME focus could reshape sponsor strategies.
Moderna shakes up leadership as COVID vaccine demand wanes—can new R&D head realign its future?
Find out why Moderna, Inc. is replacing its medical chief with a development leader and what it means for the company’s post-COVID pipeline strategy.
Amazon lost Saks, but can it still win luxury? Inside the breakup that rewrites marketplace strategy
Amazon and Saks end their luxury e-commerce partnership as bankruptcy reshapes retail alliances. Find out why it failed and what it means for luxury online.
What the end of the Kowa partnership signals for Arcutis Biotherapeutics’ commercial control of ZORYVE
Arcutis Biotherapeutics ends its Kowa partnership and takes full control of ZORYVE promotion. Find out what this signals for adoption and strategy.
Why Solid Power, Inc. is choosing dilution over delay in the race for solid-state batteries (NASDAQ: SLDP)
Solid Power, Inc. raises $130 million to extend its solid-state battery runway. Find out what the financing means for investors and execution risk.